Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11246828 Orally administered corticosteroid compositions

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
March 17, 2020
Date of Patent
February 15, 2022
Patent Application Number
16821464
Patent Citations
‌
US Patent 10272037 Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
0
‌
US Patent 10632069 Orally administered corticosteroid compositions
‌
US Patent 10471071 Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
0
‌
US Patent 11026887 Methods of treating eosinophilic esophagitis
0
‌
US Patent 10105315 Methods of treating eosinophilic esophagitis
‌
US Patent 10176301 Systems, methods, and software for providing a patient-reported outcome measure of dysphagia patients with eosinophilic esophagitis
Patent Citations Received
‌
US Patent 12059494 Methods of treating eosinophilic esophagitis
0
‌
US Patent 11684571 Methods of treating eosinophilic esophagitis
0
Patent Inventor Names
Fredric Jay Cohen
0
Gopi M. Venkatesh
0
Stephen Perrett
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11246828
Patent Primary Examiner
‌
Aradhana Sasan

Find more entities like US Patent 11246828 Orally administered corticosteroid compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo